Shots: Leo Pharma(Leo) will select the targets and MorphoSys will recognize lead molecules using peptide technology platform. Leo Pharma will either develop the lead molecules or use them to design […]readmore
Tags : Collaboration
Shots: Gilead will be paying Precision $445M as a milestone payment at specific development stages in addition to the double digit royalties (<19%) from sales Under the agreement, Precision will […]readmore
Shots: NovellusDx will provide its functional genomics assay FACT (Functional Annotation for Cancer Treatment) to Primetech, for pre-clinical market with sales, marketing and research/technical support in Japan exclusively FACT has […]readmore
Shots: This collaboration plans to use human genetics and machine learning to address unmet needs by developing precision medicines Vertex will make £25M series B funding in Genomics (£10.5M equity […]readmore
Shots: The collaboration is for development and commercialization of novel NK cell engager-based immunotherapeutics to treat multiple cancers Affimed’s will use its ROCK platform (Redirected Optimized Cell Killing) to develop […]readmore
Shots: Mallinckrodt funds Washington University with $10Mn over a period of five years with focus on rare disease Mallinckrodt plans to fund additional two grant namely: o Program grants- intended […]readmore
Shots: Collaboration is focused on using Regeneron’s Velocisuite platform for the discovery and characterization of human antibodies, T cell receptors and bluebird will contribute in gene transfer and cell therapy […]readmore
Shots: Under the expansion collaboration, new arm of assessment is added assessing BL-8040, Keytruda and chemo in 2L patient in COMBAT/KEYNOTE-202 study Results of Ph2a COMBAT study is expected in […]readmore